糖尿病網膜症（Diabetic Retinopathy）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Diabetic Retinopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Diabetic Retinopathy to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Diabetic Retinopathy to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Diabetic Retinopathy 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Diabetic Retinopathy Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Diabetic Retinopathy 34
Jun 03, 2013: Oxford BioMedic Voluntarily Pauses Recruitment Into Phase I Study Of RetinoStat 34
May 07, 2012: Promedior Presents Preclinical Data Of Pentraxin-2 At ARVO Annual Meeting 34
May 01, 2012: Promedior To Present Data From Preclinical Studies Of Pentraxin-2 At ARVO Annual Meeting 35
May 01, 2012: Promedior To Present Preclinical Data Of Pentraxin-2 At ARVO Annual Meeting 35
Mar 19, 2012: Ampio Announces Positive Preliminary Update On Optina Clinical Trial To Treat Diabetic Macular Edema 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Valeant Pharmaceuticals International, Inc. 40
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 40
Allergan, Inc. 41
Clinical Trial Overview of Allergan, Inc. 41
Takeda Pharmaceutical Company Limited 42
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 42
Eli Lilly and Company 43
Clinical Trial Overview of Eli Lilly and Company 43
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
BCN Peptides, S.A. 45
Clinical Trial Overview of BCN Peptides, S.A. 45
Clinical Trial Overview of Top Institutes / Government 46
National Eye Institute 46
Clinical Trial Overview of National Eye Institute 46
University of Sao Paulo 47
Clinical Trial Overview of University of Sao Paulo 47
National Taiwan University Hospital 48
Clinical Trial Overview of National Taiwan University Hospital 48
Association for Innovation and Biomedical Research on Light and Image 49
Clinical Trial Overview of Association for Innovation and Biomedical Research on Light and Image 49
Medical University of Vienna 50
Clinical Trial Overview of Medical University of Vienna 50
Moorfields Eye Hospital NHS Foundation Trust 51
Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust 51
Diabetic Retinopathy Clinical Research Network 52
Clinical Trial Overview of Diabetic Retinopathy Clinical Research Network 52
Shahid Beheshti University of Medical Sciences 53
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 53
HOSPITAL JUAREZ DE MEXICO 54
Clinical Trial Overview of HOSPITAL JUAREZ DE MEXICO 54
Federal University of Sao Paulo 55
Clinical Trial Overview of Federal University of Sao Paulo 55
Five Key Clinical Profiles 56
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 119